Suchergebnisse - "Wei, Andrew"

PubPharm (322)

1

Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers

enthalten in: Cancer cell | 2024

von Diepstraten, S. | Yuan, Y. | La Marca, J. | +14

2

Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Rajakumaraswamy, N. | Gandhi, M. | Wei, A. | +8

3

Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)

enthalten in: Leukemia & lymphoma | 2024

von Cortes, J. | Jonas, B. | Schiller, G. | +9

4

How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?

enthalten in: Blood cancer journal | 2024

von Tiong, I. | Wall, M. | Bajel, A. | +36

5

Genome-widein vivoCRISPR screens identify GATOR1 as a potent tumor suppressor and its loss sensitizes MYC-driven lymphomas to mTOR inhibition

enthalten in: bioRxiv.org | 2024

von Potts, M. | Mizutani, S. | Deng, Y. | +27

6

Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001

enthalten in: British journal of haematology | 2024

von Ravandi, F. | Döhner, H. | Wei, A. | +10

7

Gilteritinib as Post-Transplant Maintenance for Acute Myeloid Leukemia With Internal Tandem Duplication Mutation of FLT3

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Levis, M. | Hamadani, M. | Logan, B. | +137

8

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine : A Prospective Phase II Study (VALDAC)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Tiong, I. | Hiwase, D. | Abro, E. | +17

9

Single-cell Rapid Capture Hybridization sequencing (scRaCH-seq) to reliably detect isoform usage and coding mutations in targeted genes at a single-cell level

enthalten in: bioRxiv.org | 2024

von Peng, H. | Jabbari, J. | Tian, L. | +9

10

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia : a report of 7235 patients from seven cohorts

enthalten in: Leukemia | 2024

von Appelbaum, J. | Wei, A. | Mandrekar, S. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]